Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ketamine vs. Midazolam in Bipolar Depression

NCT01944293 is registered in ClinicalTrials.gov with New York State Psychiatric Institute as lead sponsor.

NCT NCT01944293
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01944293 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ketamine vs. Midazolam in Bipolar Depression
Lead sponsor
New York State Psychiatric Institute
Phase
Phase 1/2
Overall status
Completed
Start date
September 30, 2013
Completion date
October 31, 2018
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar disorder, major depressive episode, suicidal ideation